A theory of multi-site vaccination for cancer

Physica A: Statistical Mechanics and its Applications

Volumn 366, Issue , 2006, Pages 347-364

  Yang, Ming ^a   Park, Jeong Man ^a,b   Deem, Michael W ^a  

^a Rice University   (United States)

^b The Catholic University of Korea   (South Korea)

Author keywords

Cancer; Generalized NK model; Vaccine

Indexed keywords

CELLS; DISEASE CONTROL; IMMUNIZATION; MUTAGENESIS; STATISTICAL MECHANICS; TUMORS; VACCINES;

MUTATION; PERCOLATION TRANSITION; PROLIFERATE CANCER CELLS; VACCINATION;

ONCOLOGY;

EID: 33748054796     PISSN: 03784371     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.physa.2006.01.072     Document Type: Article

References (64)

1. Schodin B.A., Tsomides T.J., and Kranz D.M. Correlation between the number of T cell receptors required for T cell activation and TCR-ligand affinity. Immunity 5 (1996) 137-146
2. van der Merwe P.A., and Davis S.J. Molecular interactions mediating T cell antigen recognition. Annu. Rev. Immunol. 21 (2003) 659-684
3. Marrack P., and Kappler J. Control of T cell viability. Annu. Rev. Immunol. 22 (2004) 765-787
4. Zinkernagel R.M. On natural and artificial vaccinations. Annu. Rev. Immunol. 21 (2003) 515-546
5. Arstila T.P., Casrouge A., Baron V., Even J., Kanellopoulos J., and Kourilsky P. Direct estimate of the human α β T cell receptor diversity. Science 286 (1999) 958-961
6. Blattman J.N., Sourdive D.J.D., Murali-Krishna K., Ahmed R., and Altman J.D. Evolution of the T cell repertoire during primary, memory, and recall responses to viral infection. J. Immunol. 165 (2000) 6081-6090
7. Busch D.H., and Pamer E.G. T cell affinity maturation by selective expansion during infection. J. Exp. Med. 189 (1999) 701-709
8. Kassiotis G., Zamoyska R., and Stockinger B. Involvement of avidity for major histocompatibility complex in homeostasis of naive and memory T cells. J. Exp. Med. 197 (2003) 1007-1016
9. Kieper W.C., Burghardt J.T., and Surh C.D. A role for TCR affinity in regulating naive T cell homeostasis. J. Immunol. 172 (2004) 40-44
10. Sourdive D.J.D., Murali-Krishna K., Altman J.D., Zajac A.J., Whitmire J.K., Pannetier C., Kourilsky P., Evavold B., Sette A., and Ahmed R. Conserved T cell receptor repertoire in primary and memory CD8 T cell responses to an accute viral infection. J. Exp. Med. 188 (1998) 71-82
11. Welsh R.M., Selin L.K., and Szomolanyi-Tsuda E. Immunological memory to viral infections. Annu. Rev. Immunol. 22 (2004) 711-743
12. Sprent J. Life-spans of naive, memory and effector lymphocytes. Curr. Opin. Immunol. 5 (1993) 433-438
13. Sallusto F., Geginat J., and Lanzavecchia A. Central memory and effector memory T cell subsets: function, generation and maintenance. Annu. Rev. Immunol 22 (2004) 745-763
14. Crotty S., and Ahmed R. Immunological memory in humans. Seminars in Immunol 16 (2004) 197-203
15. Roy-Prouix G., Meunier M.-C., Lanteigne A.-M., and Brochu S. Immunodomination results from functional differences between competing CTLs. Eur. J. Immunol 31 (2001) 2284-2292
16. Schreiber H., Wu T.H., Nachman J., and Kast W.M. Immunodominance and tumor escape. Cancer Biol. 12 (2002) 25-31
17. Malmberg K.-J. Effective immunotherapy against cancer. Cancer Immunol. Immunother. 53 (2004) 879-892
18. Khong H.T., and Restifo N.P. Natural selection of tumor variants in the generation of "tumor escape" phenotypes. Nature Immunol. 3 (2002) 999-1005
19. Dunn G.P., Old L.J., and Schreiber R.D. The three Es of cancer immunoediting. Annu. Rev. Immunol. 22 (2004) 329-360
20. Campoli M., Chang C.-C., and Ferrone S. HLA class I antigen loss, tumor immune escape and immune selection. Vaccine 20 (2002) A40-A45
21. Müller L., Kiessling R., Rees R.C., and Pawelec G. Escape mechanisms in tumor immunity: An update. J. Env. Path., Tox. Onc. 21 (2002) 277-330
22. Stockinger B., Barthlott T., and Kassiotis G. The concept of space and competition in immune regulation. Immunology 111 (2004) 241-247
23. Waes C.V., Monach P.A., Urban J.L., Wortzel R.D., and Schreiber H. Immunodominance deters the response to other tumor antigens thereby favoring escape: Prevention by vaccination with tumor variants selected with cloned cytolytic T cells in vitro. Tissue Antigens 47 (1996) 399-407
24. Melief C.J., and Kast W.M. Prospects for T cell immunotherapy of tumors by vaccination with immunodominant and subdominant peptides. Ciba Found. Symp. 187 (1994) 97-104
25. Feltkamp M.C., Vreugdenhil G.R., Vierboom M.P., Ras E., and van der Burg S.H. Cytotoxic T lymphocytes raised against a subdominant epitope offered as a synthetic peptide eradicate human papillomavirus type 16-induced tumors. Eur. J. Immunol. 25 (1995) 2638-2642
26. Hanahan D., and Weinberg R.A. The hallmarks of cancer. Cell 100 (2000) 57-70
27. Deem M.W., and Lee H.-Y. Sequence space localization in the immune system response to vaccination and disease. Phys. Rev. Lett. 91 (2003) 068101
28. Munoz E.T., and Deem M.W. Epitope analysis for influenza vaccine design. Vaccine 23 (2005) 1142-1146
29. Park J.-M., and Deem M.W. Correlations in the T cell response to altered peptide ligands. Physica A 341 (2004) 455-470
30. V. Gupta, D.J. Earl, M.W. Deem, Quantifying influenza vaccine efficacy and antigenic distance, Vaccine 24 (2006) 2451-2459, doi:10.1016/j.vaccine.2006.01.010.
31. Bogarad L.D., and Deem M.W. A hierarchical approach to protein molecular evolution. Proc. Natl. Acad. Sci. USA 96 (1999) 2591-2595
32. Bohr N. Neutron capture and nuclear constitution. Nature 137 (1936) 344-348
33. Guhr T., Müller-Groeling A., and Weidenmüller H.A. Random-matrix theories in quantum physics: common concepts. Phys. Rep. 299 (1998) 189-425
34. Sherrington D., and Kirkpatrick S. Solvable model of a spin glass. Phys. Rev. Lett. 35 (1975) 1792-1796
35. Derrida B. Random energy model-limit of a family of disordered models. Phys. Rev. Lett. 45 (1980) 79-82
36. Bryngelson J.D., and Wolynes P.G. Spin glasses and the statistical mechanics of protein folding. Proc. Natl. Acad. Sci. USA 84 (1987) 7524-7528
37. Gutin A.M., and Shakhnovich E.I. Ground state of random copolymers and the discrete random energy model. J. Chem. Phys. 98 (1993) 8174-8177
38. Derrida B., and Peliti L. Evolution in a flat fitness landscape. Bull. Math. Biol. 53 (1991) 355-382
39. Weisbuch G. A shape space approach to the dynamics of the immune system. J. Theor. Biol. 143 (1990) 507-522
40. Drossel B. Biological evolution and statistical physics. Adv. Phys. 50 (2001) 209-295
41. Zinkernagel R.M., and Hengartner H. Regulation of the immune response by antigen. Science 293 (2001) 251-253
42. Goldrath A.W., and Bevan M.J. Selecting and maintaining a diverse T-cell repertoire. Nature 402 (1999) 255-262
43. Robinson H.L., and Amara R.R. T cell vaccines for microbial infections. Nature Med. 11 (2005) S25-S32
44. Davis M.M., Krogsgaard M., Huppa J.B., Sumen C., Prubhoo M.A., Irvine D.J., Wu L.C., and Ehrlich L. Dynamics of cell surface molecules during T cell recognition. Annu. Rev. Biochem. 72 (2003) 717-742
45. Ge Q., Bai A., Jones B., Eisen H.N., and Chen J. Competition for self-peptide-MHC complexes and cytokines between naive and memory CD8+ T cells expressing the same or different T cell receptors. Immunol. 101 (2004) 3041-3046
46. Kedl R.M., Kappler J.W., and Marrack P. Epitope dominance, competition and T cell affinity maturation. Curr. Opin. Immunol. 15 (2003) 120-127
47. Lanzavecchia A. Lack of fair play in the T cell response. Nature Immunol. 3 (2002) 9-10
48. Kedl R.M., Schaefer B.C., Kappler J.W., and Marrack P. T cells down-modulate peptide-MHC complexes on APCs in vivo. Nature Immunol. 3 (2002) 27-32
49. Berard M., and Tough D.F. Qualitative differences between naïve and memory T cells. Immunol. 106 (2002) 127-138
50. Kesmir C., Borghans J.A.M., and de Boer R.J. Diversity of human α β T cell receptors. Science 288 (2000) 1135
51. Janeway C.A., Travers P., Walport M., and Shlomchik M. Immunobiology: The Immune System in Health and Disease. sixth ed. (2004), Taylor & Francis, New York
52. Singh R.A.K., Rodgers J.R., and Barry M.A. The role of T cell antagonism and original antigenic sin in genetic immunization. J. Immunol. 169 (2002) 6779-6786
53. Natarajan L., Berry C.C., and Gasche C. Estimation of spontaneous mutation rates. Biometrics 59 (2003) 555-561
54. Tomlinson I.P.M., Novelli M.R., and Bodmer W.F. The mutation rate and cancer. Proc. Nat. Acad. Sci. USA 93 (1996) 14800-14803
55. Brossart P., Wirths S., Stuhler G., Reichardt V.L., Kanz L., and Brugger W. Induction of cytotoxic T-lymphocyte responses in vivo after vaccinations with peptide-pulsed dendritic cells. Blood 96 (2000) 3102-3108
56. Nikolich-Zugich J., Slifka M.K., and Messaoudi I. The many important facets of T-cell repertoire diversity. Nat. Rev. Immunol. 4 (2004) 123-132
57. Dubey P., Hendrickson R.C., Meredith S.C., Siegel C.T., Shabanowitz J., Skipper J.C.A., Engelhard V.H., Hunt D.F., and Schreiber H. The immunodominant antigen of an ultraviolet-induced regressor tumor is generated by a somatic point mutation in the DEAD box helicase p68. J. Exp. Med. 185 (1997) 695-705
58. Spiotto M.T., Rowley D.A., and Schreiber H. Bystander elimination of antigen loss variants in established tumors. Nature Med. 10 (2004) 294-298
59. Kupper T.S., and Fuhlbrigge R.C. Immune surveillance in the skin: mechanisms and clinical consequences. Nat. Immunol. 4 (2004) 211-222
60. Ruiz-Cabello F., and Garrido F. HLA and cancer: from research to clinical impact. Immunol. Today 19 (1998) 539-542
61. Marincola F.M., Jaffee E.M., Hicklin D.J., and Ferrone S. Escape of human solid tumors from T-cell recognition: molecular mechanisms and functional significance. Adv. Immunol. 74 (2000) 181-273
62. Natali P.G., Bigotti A., Nicotra M.R., Viora M., Manfredi D., and Ferrone S. Distribution of human class I (HLA-A, B, C) histocompatability antigens in normal and malignant tissues of nonlymphoid origin. Cancer Res. 44 (1984) 4679-4687
63. Mapara M.Y., and Sykes M. Tolerance and cancer: mechanisms of tumor evasion and strategies for breaking tolerance. J. Clin. Oncol. 22 (2004) 1136-1151
64. Sprent J., and Surh C.D. T cell memory. Annu. Rev. Immunol. 20 (2002) 551-579